Herein, we present a detailed case of an EGFR-mutant LCNEC that underwent sequential morphologic evolution into SCLC and subsequently displayed characteristics consistent with adenocarcinoma, underscoring the dynamic nature of therapeutic resistance and the value of adaptive treatment strategies (6). This evidence concerns the gene EGFR and large cell neuroendocrine carcinoma.